title: [A case report of an advanced esophageal carcinoma (stage II) without signs of recurrence in 5 years after chemoradiotherapy. With reference to p53 immunohistochemistry as an indicator for prognostic evaluation of chemoradiotherapy].
authors.affiliation: Department of Internal Medicine, Social Welfare Corporation, Hokkaido Social Work Association, Otaru Hospital.
authors.forename: Keiki
authors.initials: K
authors.lastname: Isogai
authors.forename: Reine
authors.initials: R
authors.lastname: Moriuchi
authors.forename: Isao
authors.initials: I
authors.lastname: Tarasawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Yabana
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Kato
authors.forename: Seiya
authors.initials: S
authors.lastname: Nakahara
authors.forename: Rieko
authors.initials: R
authors.lastname: Murakami
authors.forename: Akinori
authors.initials: A
authors.lastname: Senota
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Ban
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
chemical_list: D016159:Tumor Suppressor Protein p53; D002945:Cisplatin; D005472:Fluorouracil